𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunofluorescent quantification of tyrosine phosphorylation of cellular proteins in whole cells by flow cytometry

✍ Scribed by Dariush Farahi Far; Jean-François Peyron; Veronique Imbert; Bernard Rossi

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
786 KB
Volume
15
Category
Article
ISSN
0196-4763

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis by flow cytometry of tyrosine-p
Analysis by flow cytometry of tyrosine-phosphorylated proteins in activated T-cell subsets on whole blood samples
✍ Pascale Hubert; Pierre Grenot; Brigitte Autran; Patrice Debré 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 2 views

Tyrosine phosphorylation of cellular proteins is a critical early event in the T-cell activation process induced by the antigenic peptide or monoclonal antibodies specific for the CD3 T-cell receptor (TCR) complex. Phosphoproteins are currently detected by Western blotting experiments or, recently,

Cellular heterogeneity of DNA/total-prot
Cellular heterogeneity of DNA/total-protein content in human lung tumors, as determined by flow cytometry
✍ L. Teodori; M. L. Trinca; F. Salvati; L. Berettoni; G. Storniello; W. Göhde 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 742 KB

## Abstract With the aim of distinguishing neoplastic cell sub‐populations of different prognostic and diagnostic significance, dual‐parameter measurements (DNA/protein) have been simultaneously determined in a (256, 256) channel matrix in lung samples derived from 110 patients affected by neoplast

Monitoring of FLT3 phosphorylation statu
Monitoring of FLT3 phosphorylation status and its response to drugs by flow cytometry in AML blast cells
✍ Tiziana Grafone; Michela Palmisano; Chiara Nicci; Alberto Maria Martelli; Ottavi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 360 KB

## Abstract __FLT3__ mutation and overexpression in most acute myeloid leukaemia (AML) patients make this tyrosine kinase receptor an attractive therapeutic target. FLT3 kinase inhibitors are actually in clinical trials, thus it is critical to develop a reproducible and standardized method for scre